Intuitive Surgical has overhauled its corporate bylaws, reshaping shareholder nomination, proposal, and special meeting rules, while its stock trades well below recent highs. The share price is down 35.62% year to date and 20.28% over the past 90 days, closing at $361.80, even as the three-year total shareholder return remains positive at 11.68%. A widely followed fair value estimate of $630.48 suggests the stock is 42.6% undervalued, based on strong margins, steady revenue growth, and a premium earnings multiple. However, the recent price decline, a new shelf registration, and tighter governance rules could challenge that narrative if sentiment weakens further. On an earnings basis, the stock trades at a P/E of 40.7x, above the fair ratio of 34.5x, the US Medical Equipment industry at 29.1x, and peers at 29.2x, indicating a richer valuation.
Intuitive Surgical IncArticle discusses bylaw changes, shelf registration, and a fair value estimate suggesting undervaluation, but also notes high P/E and potential sentiment weakness.